Citations

Clear

513 citation(s) found for "Ta, Casey".

Safety and efficacy of MicroPulse transscleral laser therapy with the revised P3 delivery device: A randomized controlled trial
Lentz, P. Connor , Wagner, Isabella V. , Kumar, Devesh , Boopathiraj, Nithya , Ahuja, Abhimanyu S. , Checo, Leticia , Miller, Darby D. , Dorairaj, Syril , Ahuja, Abhimanyu , Checo, Leticia , Miller, Darby D , Dorairaj, Syril , Wagner, Isabella V , Lentz, P Connor , Ang, Bryan C H

Mayo Clinic

European Journal of Ophthalmology | May 8, 2025 | Volume: 35 | Issue: 5 | Pages: 1863-1874

10.1177/11206721251340102 | PMID 40336295 Get It

Objective To evaluate the safety and efficacy of MicroPulse Transscleral Laser Therapy (MicroPulse TLT) with the Revised P3 ® Delivery Device. Design Prospective, single-surgeon, interventional study in a tertiary hospital setting. Participants Sixty-two eyes of 40 patients with refractory glaucoma. Methods All subjects received 360-degree MicroPulse TLT treatment (2500 mW, 31.33% duty cycle) over a total of 240 s (8 sweeps; n = 20), 300 s (10 sweeps; n = 22), or 200 s (10 sweeps; n = 20). Participants were followed up for 6 months to assess changes in intraocular pressure (IOP), glaucoma medication burden, and best-corrected visual acuity (BCVA). Surgical success was defined as a reduction of IOP ≥ 30% from baseline and between 6–18 mmHg at last follow-up with no additional anti-glaucoma medications or secondary reinterventions. Results Surgical success was achieved in 72.7% (300 s group), 75.0% (240 s group), and 80.0% (200 s group) of eyes. Mean IOP was significantly reduced ( p < 0.001) by 49.0% (300 s group), 45.66% (240 s group), and 39.8% (200 s group) at 6 months. With all groups combined, the mean number of glaucoma medications was significantly reduced by 17.8% ( p = 0.005), and no significant changes in BCVA were observed at 6 months. Complications were minimal, including four eyes with IOP spikes, one eye with hyphema, and one eye with cystoid macular edema (CME), all of which resolved. Two eyes of the total sample (3.2%) required secondary glaucoma surgery before 6 months. Conclusions Second-generation MicroPulse TLT at fluence values of 154–229 J/cm 2 appears to be a safe and effective option for IOP reduction in refractory glaucoma.
In nonsevere influenza, antiviral drugs do not reduce mortality or hospital admissions; some shorten symptom duration
Clements, Casey M. , Carpenter, Christopher R.

Mayo Clinic

Annals of Internal Medicine | May 5, 2025 | Volume: 178 | Issue: 5 | Pages: JC51

10.7326/annals-25-01324-jc | PMID 40324181 Get It

Characterizing the expression profile of 3R tau pathology in Pick’s disease
Tamvaka, Nicole , Soto‐Beasley, Alexandra I. , Gavrielatos, Marios , Ren, Yingxue , Udine, Evan, Quicksall, Zachary , Liskey, Delaney , Castanedes‐Casey, Monica , Wszołek, Zbigniew K. , Boeve, Bradley F. , Josephs, Keith A. , Blitterswijk, Marka van , Murray, Melissa E. , Roemer, Shanu F. , Ross, Owen A. , Wszolek, Z.K. , Quicksall, Zachary S , Castanedes-Casey, Monica , Boeve, Brad , Josephs, Keith A , van Blitterswijk, Marka , Murray, Melissa E , Dickson, Dennis W , Ross, Owen A , Beasley, Alexandra I , Heckman, Michael G. , Udine, Evan , Graff, Caroline , Dickson, Dennis W.

Mayo Clinic

Science Advances | May 2, 2025 | Volume: 11 | Issue: 18 | Pages: No page available

10.1126/sciadv.adt6105 | PMID 40315309 Get It

Pick’s disease (PiD) is a rare neurodegenerative disorder defined by dementia, frontotemporal lobe atrophy, and 3-repeat tau inclusions. To elucidate PiD pathobiology, we performed the first bulk transcriptomics study on PiD using short- and long-read sequencing on the parietal cortex of 28 PiD and 15 control samples. We identified several significantly differentially expressed genes, with CCL2 displaying the strongest association with 3-repeat tau pathology and increased burden in PiD compared to those in 4-repeat tau progressive supranuclear palsy (PSP) cases. Investigation of co-expressed genes and pathways suggested the involvement of mRNA processing, mitochondrial function, and immune processes in disease pathobiology. Long-read RNA sequencing on a subset of samples (eight PiD and four control) proposed novel, potentially disease-associated transcripts for AZGP1 , CD44 , HSD11B2 , and WIF1 , predicted to result in truncated proteins. In conclusion, we observed transcriptomic changes in the parietal cortex of patients with PiD that may inform into clinically relevant biomarkers and therapeutic strategies.
The Future of Robotics in Plastic and Reconstructive Surgery
Payne, Camryn, Martinez, Casey , Spronsen, Nicole Van , Shrout, Max A., Morris, Bryn E., Casey, William J., Rhee, Daniel H. , Reece, Edward, Yi, Johnny , Rebecca, Alanna M. , Payne, Cynthia S. , Van Spronsen, Nicole, Shrout, Max, Casey, William, Rhee, Daniel, Rebecca, Alanna, Payne, Camryn S , Payne, Camryn, Jungbauer, Walter N

Mayo Clinic

Annals of Plastic Surgery | May 1, 2025 | Volume: 94 | Issue: 5S | Pages: S421-S424

10.1097/sap.0000000000004278 | PMID 40310003 Get It

Abstract Robots have been used effectively in plastic and reconstructive surgery (PRS) for reconstruction. The utilization of robotics in all surgical specialties is expanding with the goal of offering the most appropriate patient-centered care possible, especially in complex multidisciplinary cases. Despite the safety, efficiency, and reproducibility of robotics in PRS, there is a paucity of required and formalized training in PRS residency programs. The ACGME and industry published guidelines were investigated. Robotic surgery case logs of Mayo Clinic Arizona General Surgery residents were analyzed with attention to equivalency certification (EQ). Over the past 5 years, the equivalency certification from Intuitive (Sunnyvale, CA) was obtained by 30% of all general surgery residents at our institution (range, 0–100). The case numbers to obtain the equivalence certification are industry recommendations, and proficiency is determined by the program director. The ACGME does not mandate robotics training in general surgery residency. According to the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), trainees must complete 20 console cases and 10 bedside cases to become industry certified. With respect to training and advancing the field, PRS residents could successfully obtain certification in their residency programs. The minimum case requirement recommended by SAGES is not burdensome and can ensure robotic privileges in PRS practice immediately following graduation. By improving the training for minimally invasive robotic surgery in plastic surgery, patients and healthcare systems benefit from improved quality of life outcomes and decreased postoperative length of stay, which results in less strain on our entire medical system.
NeurAnki: Behind The Scenes of Creating the First-Ever Flashcard Based Deck for Resident Education (P12-5.009)
Albin, Casey, Saylor, Deanna , Stanley, Michael , Buletko, Andrew , Budhu, Joshua , Etter, Micah, Guduru, Zain , Kentris, Michael, Cheng‐Ching, Esteban , Budhu, Joshua A , Saylor, Deana , Marawar, Rohit , Christy, Alison , Riggins, Nina , Coon, Elizabeth A. , Roberts, Matthew, Antonio‐Santos, Aileen A.

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000208902 Get It

The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience Program
Hanauer, Stephen B. , Torres, Esther A. , Aragon-Han, Patricia, Chapman, J. Casey, Arai, Ronen, Butnariu, Mandalina, Lee, Thomas C., Rabizadeh, Shervin , Check, Morgan, Hashash, Jana G. , Meister, Thomas, Yen, Eugene F. , Kinnucan, Jami , Ziring, David , Shaposhnikov, Rimma, Sinh, Preetika , Qazi, Taha , Yarur, Andrés , Monzur, Farah , Abraham, Bincy , Lee, Thomas C , Hashash, Jana G , Sinh, Preetika , Abraham, Bincy P , Yarur, Andres J , Hanauer, Stephen B , Swaminath, Arun C. , Butnariu, Mandalina, Barrett, Terrence A. , Stein, Daniel J., Shaposhnikov, Rimma, Dervieux, Thierry

Mayo Clinic

Pharmaceutics | March 28, 2025 | Volume: 17 | Issue: 4 | Pages: 428

10.3390/pharmaceutics17040428 | PMID 40284422 Get It

Background/Objectives: This study aimed to establish the clinical utility of a therapeutic drug monitoring (TDM)-supported, model-informed precision dosing (MIPD) approach (precision-guided dosing [PGD]) by assessing the impact of pharmacokinetic (clearance [CL]) and clinical laboratory parameters on adalimumab (ADA) dosage adjustments during maintenance therapy for inflammatory bowel disease (IBD). Methods: In the EMPOWER study, blood was collected at any time post-ADA injection. Pharmacokinetic (PK) testing was conducted in an accredited lab. Inputs for the PGD test included ADA concentrations, antibodies to ADA, albumin levels, and the current dosing regimen. CL was calculated using nonlinear mixed-effect models. Results were reported to health care providers (HCPs) within 3 days. HCPs’ treatment decisions were recorded and classified as treatment reduction, continuation, intensification, or ADA discontinuation. The physician global assessment (PGA) of disease activity was collected. Relationships between drug concentrations, CL, disease activity, and physician decision-making were assessed using logistic regression. Results: A total of 213 cases were assessed by 21 HCPs. ADA treatment was intensified in 24% and discontinued in 13% of cases. An ADA concentration ≤ 10 μg/mL was associated with a 23.7-fold and 3.0-fold higher likelihood of therapy intensification and PGA > 0, respectively, compared to concentrations > 10 μg/mL. An ADA concentration < 5 μg/mL was associated with a 3.3-fold higher likelihood of treatment discontinuation. CL ≥ 0.318 L/day was associated with a 10.4-fold higher likelihood of therapy intensification. Higher CL (>0.8 L/day) was associated with a 3.5-fold and 4.2-fold higher likelihood of treatment discontinuation and PGA > 0, respectively. Conclusions: PGD enables earlier and precise optimization of ADA dosing by predicting trough levels at any time during the therapy cycle. Optimized dosing to achieve target ADA concentrations and low clearance is crucial to mitigate therapy discontinuation and active disease in IBD patients.
Assessing the beliefs and impacts of strength training in a Division I collegiate gymnastics team
Ng, Tammy , Bendrick, Tyler, Swanstrom, Mary, Casey, Ellen , Burnham, Kevin J. , Faustin, Marcia , Burnham, Kevin , Bendrick, Tyler R. , Swanstrom, Mary, Wilson, Machelle

Mayo Clinic

PM&R | March 11, 2025 | Volume: 17 | Issue: 7 | Pages: 771-781

10.1002/pmrj.13350 | PMID 40062361 Get It

AbstractBackgroundTraditionally, there has been a reluctance to use weight training with female gymnasts due to concerns that it could cause detrimental increases in muscle mass and impede flexibility. Recent literature has demonstrated that strength training has no significant effect on flexibility and can improve athletic performance.ObjectiveTo assess in a pilot study the perceptions of collegiate gymnasts and coaches toward strength training after starting inaugural strength and conditioning training.DesignSurvey‐based study.SettingNational Collegiate Athletics Association Division I women's gymnastics program at a public university in California.ParticipantsOf the 23 gymnasts surveyed, 17 (74%) responded to the survey. Of the two coaches surveyed, both (100%) responded to the survey.InterventionsNot applicable.Main Outcome MeasuresDescriptive statistics characterizing demographics, characteristics of gymnasts' strength and conditioning program, and perceptions regarding the safety of strength training and its impact on performance, body shape, flexibility, and injury rates.ResultsMost gymnasts agreed (35%) or strongly agreed (59%) that weight training may improve performance. All gymnasts disagreed (59%) or strongly disagreed (41%) that weight training is not safe; 41% disagreed, 29% strongly disagreed, and 17% agreed that weight training may negatively affect body shape. Most gymnasts disagreed (59%) or strongly disagreed (18%) that weight training decreases flexibility; four (24%) felt neutral. Eighty three percent (59% strongly agree, 24% agree) felt that weight training had a positive impact on performance. More than half of the gymnasts either agreed (24%) or strongly agreed (29%) they had fewer injuries the season after implementing weight training, compared to prior seasons. Both coaches similarly endorsed the safety of strength training and its potential to improve performance.ConclusionsIn this pilot study, collegiate gymnasts and coaches expressed generally positive perceptions toward the safety of strength training and its effect on performance. A small number of gymnasts expressed concerns regarding the effects of weight training on body shape and flexibility.
Use of Body Armor by EMS Clinicians, Workplace Violence, and Racial and Ethnic Disparities in Care
Bellolio, Fernanda , Sztajnkrycer, Matthew D. , Sveen, Michael J., Liedl, Chad P., Clements, Casey M. , McGuire, Sarayna S. , Bellolio, M Fernanda , Mullan, Aidan F.

Mayo Clinic

JAMA Network Open | January 29, 2025 | Volume: 8 | Issue: 1 | Pages: e2456528

10.1001/jamanetworkopen.2024.56528 | PMID 39878979 Get It

ImportanceThere is a clear benefit to body armor against firearms; however, it remains unclear how these vests may influence day-to-day patient encounters when worn by emergency medical services (EMS).ObjectiveTo determine the association of ballistic vests worn by EMS clinicians with workplace violence (WPV) and disparities in care among racial and/or ethnic minority patients.Design, Setting, and ParticipantsProspective cohort study of a volunteer-based sample of EMS clinicians at a large, multistate EMS agency encompassing 15 ground sites across the Midwest from April 1, 2023, to March 31, 2024. Data were analyzed from May to June 2024.ExposureExternal ballistic armor being used by a group of self-selected clinicians on every run.Main Outcomes and MeasuresPrevalence and characteristics associated with WPV and with declines of treatment and/or transport compared between crews with 1 or more vested vs no vested members.ResultsA total of 156 of 415 staff (37.6%) opted in to wear the vests, including 77 male participants (49.4%). Prevalence of WPV was higher for vested crews (1.11 vs 0.85 cases per 100 runs; adjusted risk ratio [aRR], 1.28; 95% CI, 1.10 to 1.50; P = .001) and was due to higher rates of verbal abuse. The presence of 1 or more vested crew members increased the likelihood of all patients declining EMS treatment and/or transport; however, effect size was highest among patients with an unknown race and/or ethnicity (2234 [21.1%] vs 2134 [16.5%] patients; aRR, 1.19; 95% CI, 1.10 to 1.27; P &amp;lt; .001), followed by racial and/or ethnic minority patients (708 [16.7%] vs 399 [13.8%] patients; aRR, 1.18; 95% CI, 1.05 to 1.33; P = .01). Analyses of individual minority groups revealed a significant increase only in Black or African American patients declining treatment and/or transport by vested crews (461 [17.6%] vs 223 [13.7%] patients; RR, 1.28; 95% CI, 1.10 to 1.49; P = .002).Conclusions and RelevanceIn this cohort study, vested crews experienced increased prevalence of WPV compared with nonvested crews. Use of vests increased the frequency of all patients declining EMS treatment and/or transport. Among minority groups, there was a significant increase in Black or African American patients declining treatment and/or transport. Agencies should consider benefits and unintended consequences of EMS clinicians wearing body armor.
Lymph Node Staging and Treatment in Pediatric Patients With Soft Tissue Sarcomas: A Consensus Opinion From the Children's Oncology Group, European paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe
Scheltinga, Sheila Terwisscha van , Kao, Simon C. , Keizer, Bart de , McCarville, M. Beth , Casey, Dana L. , Merks, Hans, Kapadia, Tejas , Walterhouse, David O., Hiemcke‐Jiwa, Laura S. , Franzius, Christiane, Vokuhl, Christian , Dasgupta, Roshni, Birz, Suzi , Rodeberg, David A. , Dasgupta, Roshni , Terwisscha van Scheltinga, Sheila , de Keizer, Bart , Shulkin, Barry L , Casey, Dana L , Allen-Rhoades, Wendy, Orbach, Daniel , Davila Fajardo, Raquel , Oberoi, Saphna , Vokuhl, Christian , Rodeberg, David A , Kao, Simon C , Dasgupta, Roshni , Schoot, Reineke A , Routh, Jonathan C. , Seitz, Guido , Shulkin, Barry L. , Ewijk, Roelof van , Allen‐Rhoades, Wendy , Mercolini, Federico , Merks, Hans, Fajardo, Raquel Dávila , Corti, Federica De , Tang, Vivian , Metts, Jonathan L.

Mayo Clinic

Pediatric Blood & Cancer | January 23, 2025 | Volume: 72 | Issue: 4 | Pages: No page available

10.1002/pbc.31538 | PMID 39844722 Get It

ABSTRACTAccurate staging of nodal involvement in pediatric sarcoma patients is important to determine correct systemic and local therapy, with the goal to reduce subsequent recurrences. However, differences in lymph node staging strategies, definitions, and treatment protocols between the Children's Oncology Group (COG), European paediatric Soft tissue sarcoma Study Group (EpSSG), and the Cooperative Weichteilsarkom Studiengruppe (CWS) complicate comparisons. In this article, we aim to establish internationally recognized recommendations for lymph node assessment and treatment of children and adolescents diagnosed with rhabdomyosarcoma (RMS) and non‐rhabdomyosarcoma soft tissue sarcoma (NRSTS) according to the Consensus Conference Standard Operating Procedure methodology.